Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Sarepta Therapeutics (SRPT)

35.90 -1.05 (-2.84%)

8/23/2017  2:59pm

Open:

36.57

Pre. Close:

36.95

High:

37.35

Low:

35.70

Volume:

1,195,491

Market Cap:

2.31B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

37.56 - 38.22

38.22 - 38.92

Low:

33.08 - 33.97

33.97 - 34.91

Close:

35.57 - 36.84

36.84 - 38.2

Technical analysis  (as of: 2017-08-23 2:40:49 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 47.67     One year: 51.67

Support:

Support1: 35.26    Support2: 29.34

Resistance:

Resistance1: 40.81    Resistance2: 44.24

Pivot:

37.44

Moving Averages:

MA(5): 36.41     MA(20): 37.92

MA(100): 34.38     MA(250): 35.55

MACD:

MACD(12,26): -0.23     Signal(12,26,9): 0.18

%K %D:

%K(14,3): 18.77     %D(3): 15.87

RSI:

RSI(14): 43.50

52-Week:

High: 63.73  Low: 24.96  Change(%): 39.0

Average Vol(K):

3-Month: 206815  10-Days 19815

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
SRPT has closed above bottom band by 8.4%. Bollinger Bands are 37.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 22 Aug 2017 13:07:30 GMT
Sarepta Therapeutics: Backing A Cure For Duchenne Muscular Dystrophy

Tue, 22 Aug 2017 22:30:00 GMT
Sarepta Therapeutics defeats investor lawsuit on appeal

Sat, 29 Jul 2017 09:56:15 GMT
Sarepta Therapeutics Inc (SRPT) President & CEO Douglas S Ingram Bought $2 ...

Tue, 22 Aug 2017 12:45:00 GMT
Why Is Sarepta (SRPT) Down 9.9% Since the Last Earnings Report?

Tue, 25 Jul 2017 00:00:00 GMT
Sarepta Therapeutics Announces Pricing of $325 Million Public Offering of ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

64.33

Shares Float (M)

60.38

% Held by Insiders

7.79

% Held by Institutions

61.20

Shares Short (K)

11290

Shares Short Prior Month (K)

12350

Stock Financials

EPS

-2.420

EPS Est. Current Year

-1.160

EPS Est. Next Year

-1.650

EPS Est. Next Quarter

-0.630

Forward EPS

-1.720

Book Value (p.s.)

7.810

PEG Ratio

158.90

Profit Margin

-218.67

Operating Margin

-413.60

Return on Assets (ttm)

-44.9

Return on Equity (ttm)

-49.7

Qtrly Rev. Growth

Gross Profit (p.s.)

0.082

Sales Per Share

EBITDA (p.s.)

-3.567

Qtrly Earnings Growth

Operating Cash Flow (M)

-284.88

Levered Free Cash Flow (M)

-59.29

FoxReading.com

Valuation

P/E

-14.80

P/E Growth Ratio

-0.03

P/BV

4.59

P/S

2152950784.00

P/CF

-8.09

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-07-12

Last Split Ratio

0.17

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.